Modern Vascular Announces Hiring of Dr. Steve Berkowitz

Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of peripheral artery disease (PAD), today announced the hiring of Dr. Steve Berkowitz, a nationally recognized healthcare leader with over 25 years of experience in senior management, protocol standardization, and clinical oversight.

Previous Experience

Dr. Berkowitz comes to Modern Vascular from Banner Health in Phoenix, Arizona, where he served as the organization’s Medical Director of Specialty Performance Improvement. Prior to that position, he was the Chief Physician Executive and medical group president for Northern Light Health, a nine-hospital system in Maine. He’s also held the title of Chief Medical Officer at St. David’s Healthcare, a six-hospital system in Austin, Texas and at the Central and West Texas Division of HCA, which was awarded the Texas Award for Performance Excellence and the prestigious Malcolm Baldrige National Quality award.

“I am thrilled to join the Modern Vascular team,” Dr. Berkowitz said. “The organization is dedicated to saving patients from the unnecessary risk and cost associated with amputations. I have seen the work that is being done in their clinics and am convinced their treatments represent the gold-standard for PAD care. I was also impressed by Modern Vascular’s commitment to caring for underserved communities, especially indigenous populations in the American Southwest.”

Board Certified

Dr. Berkowitz, who is board certified in internal medicine, said he found Modern Vascular’s approach especially appealing because the procedures are minimally invasive, which means no general anesthesia and no surgery. This is particularly important given the typical age and health status of patients with peripheral artery disease. “Unfortunately, many patients are encouraged to undergo invasive vascular surgeries requiring hospitalization, and even amputations, a high-risk and life-altering surgery,” he added. “While amputations might be profitable for some practices, I believe patients and their quality-of-life matter more than profit. And I’m proud to work for a company with the mission of eliminating unnecessary amputations as the standard treatment for those with peripheral artery disease.”

New Role

In his new role, Dr. Berkowitz will ensure the best-in-class standards of care already in place at Modern Vascular clinics are enhanced, improved, and implemented as the company expands. He will also oversee the multidisciplinary panel of healthcare professionals employed by Modern Vascular, which includes Interventional Radiologists, Vascular Surgeons, and Interventional Cardiologists at the company’s 14 clinics nationwide.

“We are thrilled to welcome Dr. Berkowitz to the Modern Vascular family,” noted Dr. Yury Gampel, the company’s founder and CEO. “As the demand for our minimally invasive services continues to grow and we open more clinics across the country, it is imperative for Modern Vascular to have a full-time Chief Medical Officer who will be an advocate for innovative quality measures that improve the lives of our patients.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.